These emerging therapies, including Rybelsus, belong to a class of drugs called GLP-1 receptor agonists . Originally developed for treating high blood sugar, they work by assisting the body to produce adequate insulin and curbing excessive blood sugar levels. Beyond diabetes, their capacity to promote weight management has led to increased discussi